ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.
Lung Cancer Gets Less Press, Study Finds
Vanderbilt Wins Lung Cancer SPORE Grant.
Vanderbilt, Jonsson Centers Win NCI SPORE Grants.
Prevention Trials Should Get More Funding, Coltman Says.
FDA Approves Gleevec In 73 Days, A Speed Record.
Pesticides Not Linked To High Rates Of Breast Cancer.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research









